Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Material-Sparing Strategies for Rapid Development and Scale-Up of Complex Drug Products
In an industry where complex molecules and first-in-human (FIH) formulations often come with very limited API supply, material-sparing strategies are central to efficient CMC development. read more
Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Executive Q&A - Early Drug Development
In this Q&A, we explore early-stage pharmaceutical drug development trends, key scientific and technical challenges, and the role emerging technologies play in enhancing efficiency and quality during early pharmaceutical development. read more
Shore to Please
As this year is coming rapidly to a close, I thought it might be interesting to review the ten biggest announced projects since January: read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

SGS Expands Bioanalytical Testing Capabilities in North America with Acquisition of CMIC, INC.
Thursday, June 04, 2026
SGS announced that it has acquired CMIC, INC., a specialized provider of bioanalytical testing services based in Chicago, Illinois. read more
Sygnature Discovery, DaltonTx Partner to Expand AI-Enabled Drug Discovery
Thursday, June 04, 2026
Sygnature Discovery announced a strategic collaboration with DaltonTx to strengthen its AI-enabled drug discovery capabilities and accelerate ... read more
Stipple Bio, Lonza Sign Multi-Target ADC Licensing Agreement
Thursday, June 04, 2026
Lonza and Stipple Bio announced a multi-target licensing agreement to support the development of next-generation precision oncology antibody-drug ... read more
Made Scientific Selected as Manufacturer for Columbia University's Autologous and Allogeneic NOVAKnee Program - a First-in-Class Living Biologic Total Knee Replacement
Thursday, June 04, 2026
Made Scientific has been selected as manufacturer for NOVAKnee, a first-in-class living biologic total knee replacement being developed by researchers... read more
CPHI Americas to Relocate to Miami in 2027
Tuesday, June 02, 2026
Informa Markets, organizer of CPHI Americas, will move the event to Miami in 2027 to enhance international accessibility, increase executive ... read more